After 5 Years Cervical Cancer Vaccine Tested in Brazil and US Keeps Working

    Young woman gets a cervical cancer vaccine shot

    Young woman gets a cervical cancer vaccine shot As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.

    Today at the 2007 Annual Meeting of the American Association for Cancer Research, presentations on ongoing HPV trials and other new approaches to stimulating the immune system are injecting momentum into cancer vaccine research.

    Ongoing evaluation of a phase II trial of a human papillomavirus vaccine, developed to prevent cervical cancer, shows that the vaccine continues to protect against HPV types 16 and 18 at five and a half years into the study, according to researchers from the University of Louisville. Their findings also show that the vaccine offers significant cross-protection for HPV types 45 and 31.

    The study follows 1113 women between the ages of 15 and 25 in North America and Brazil randomized to receive three doses of either the vaccine or the control. The vaccine, made by GlaxoSmithKline, which funded the study, is designed to protect against two strains of HPV, types 16 and 18, which together are thought to cause nearly 72 percent of all cases of cervical cancer.

    At over five years into the study’s follow-up, the researchers found that approximately 98 percent of subjects still maintained protection against HPV types 16 and 18. Regardless of HPV status, the vaccine also appears to prevent most occurrences of cervical intraepithelial neoplasia lesions – abnormal, precancerous cell growths found in the cervix.

    They also found that the vaccination offered significant protection against genetically similar viruses. They determined the vaccine to be 88 percent effective against HPV type 45 and 54 percent effective against HPV type 31.

    "Overall, it is not a surprise that the vaccine offers protection against additional types of human papillomavirus, as they are all related genetically," said Stanley Gall, M.D., professor at the University of Louisville. "However, as you get genetically farther from types 16 and 18, you would expect to see less cross-protection."

    According to Dr. Gall, effective preventative treatment with the vaccine will depend on the long-term and broad protection the vaccine can offer against cancer-causing HPV types.

    Tags:

    • Show Comments (0)

    Your email address will not be published. Required fields are marked *

    comment *

    • name *

    • email *

    • website *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Ads

    You May Also Like

    People for Export

    If the exodus has helped in some way to alleviate the unemployment problem the ...

    Best-seller Books, Plays and Movies

    By Brazzil Magazine RIO Se Correr o Bicho Pega, Se Ficar o Bicho Come ...

    Exports Are Down But Brazilians Are Eating More Chicken

    Bird flu, which killed thousands of chickens in Asian countries in 2005, caused Brazilian ...

    Brazil Ready to Stay 10 Years in Haiti

    Brazilian General Augusto Heleno Ribeiro, commander of the United Nations Peace Forces in Haiti, ...

    Top Names in Brazilian Fashion Have Arab Blood

    They grew up listening to the their parents and grandparents speaking in Arabic. At ...

    Brazil to Train 300,000 Youngsters

    More than 300 thousand Brazilian young people in the 16-24 age bracket will receive ...

    Brazilian Pinesso

    For Some Brazilian Farmers Africa Is the New Frontier

    Frademir Saccol is Brazilian and, until late 2008, lived a peaceful life in the ...

    Kerry Snubs Brazil and Latin America

    John Kerry had the right woman at his side when accepting the Democratic nomination ...

    How Nestlí©’s Work Relations Have Soured in Brazil

    The Nestlé plant in Araras, near São Paulo, is the biggest Nestlé plant in ...

    Middle East Woos Brazilian Entrepreneurs

    The negotiations between entrepreneurs from Brazil and importers and exporters from Iraq, Jordan, Lebanon, ...